Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases
Daniela Massi(University of Florence), Angelo Paolo Dei Tos(University of Padua), Thomas Mentzel(University of Freiburg), John Panelos(University of Ioannina), Alessandro Franchi(University of Pisa), Marco Santucci(University of Florence), Aikaterini Zioga(University of Ioannina), Michal Michal(Charles University), Gabrina Tragni(Tumori Foundation), José Luis Rodríguez‐Peralto(Research Institute Hospital 12 de Octubre), Gerardo Ferrara(Azienda Ospedaliera G.Rummo), Silvana Di Palma(Royal Surrey County Hospital), Martin Cook(Royal Surrey NHS Foundation Trust), Dmitry V. Kazakov(Idiap Research Institute), Ana B. Enguita(Spanish Society of Hematology and Hemotherapy), Llúcia Alós(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)
Cited by 120
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k